Financial plays

The new company has a target of €2.5m in revenue for 2014.

Solvay management buys out Solactis

By Shane STARLING

€13bn Belgian supplier Solvay has sold its Solactis nutrition division that includes galactofructose  (lactulose) to its former nutrition programme manager.

T&L CEO Javed Ahmed: “The difference in the business today is if the US had anaemic growth we would not have been able to address that.”

Tate & Lyle meeting profit targets despite 4% US soft drink slide

By Shane STARLING

Tate & Lyle CEO Javed Ahmed says earning and profit forecasts are intact – “mid single digit growth” – despite an unseasonably cold spring that has contributed to an annual drop of 4% in the US soft drinks market and hit its specialty and bulk sweeteners...

[Left to right]: Prof Gerald Fitzgerald, APC deputy director; Prof Gerry Boyle, director Teagasc; Sean Sherlock, TD, minister for science and innovation; prof Fergus Shanahan, director APC; Dr Sally Cudmore, APC general manager; prof Mark Ferguson, director General, Science Foundation Ireland and chief science advisor to the Irish Government; Dr Michael Murphy, president UCC

Irish microbiota research centre to receive €50m boost

By Shane STARLING

The Alimentary Pharmabiotic Centre (APC) in Cork, Ireland has received a €36m investment from the Irish government that will fund its research activities for at least another six years, its GM told us this morning.

“…the Board does not believe that the market fully appreciates the value of the Science in Sport Business...

Provexis seeks to demerge Science in Sport and Fruitflow

UK firm Provexis has filed to demerge the Science in Sport (SiS) consumer sports brand it purchased for €10m in June 2011 from its Fruitflow tomato-based ingredients business, as it believes the separation will increase the market value and perception...

DSM Q1 sales steady; happy with acquisitions

DSM Q1 sales steady; happy with acquisitions

Strong nutrition sales drove a steady quarter at DSM with sales up 10% in that division, as EBITDA profits improved €5m across the company to €311m compared to €306m in Q1 2012.

Q1 2013: Naturex net profit up 67%

Q1 2013: Naturex net profit up 67%

Naturex has seen sales rise 13.2% to €83.2m in Q1 2013, with Nutrition its star core business performer, leaping about 33% from €22m to just over €29m.

Asian demand for baby food was a major driver of Danone's sales increase

Danone results get Asia baby food boost

By Caroline SCOTT-THOMAS

Danone reported sales growth in the first quarter of 2013 as demand for baby food in Asia boosted profits, despite continued weakness in Europe.

Forté Pharma sales up 1.5% in 2012

Forté Pharma sales up 1.5% in 2012

By Shane Starling

2012 sales have risen 1.5% at Forté Pharma, the food supplements arm of Spanish player Natraceutical, with weight management products dominating.

Nestlé buys Louisiana depression food firm

Nestlé buys Louisiana depression food firm

By Shane STARLING

Nestlé has bought its second brain health-focused medical foods start-up in eight months after snaffling Red River Pharma-owned Pamlab which makes high-dose vitamin supplements targeting depression, diabetes and Alzheimer’s.

How high can high-end omega-3 go?

Special edition: Omega-3 (Editor's blog)

How high can high-end omega-3 go?

By Shane STARLING

Just got off the phone to Ola Snove, the new(ish) CEO of Aker part-owned Norwegian omega-3 specialist Epax. Wanted to know his view on high-end omega-3 prospects that have attracted BASF and DSM to the sector. His word: “Stellar”.

Probi 2012 sales up 6%, but ProViva royalties set for dive

Probi 2012 sales up 6%, but ProViva royalties set for dive

By Shane Starling

The European probiotic sector is bracing itself for tough times ahead in the wake of December’s  EU health claim ban for the sector, but the effects are yet to be felt at Swedish supplier Probi which notched 6% sales growth in 2012.

Chobani’s global ambitions: Too much, too young?

EDITOR'S OPINION: DEAR DAIRY....

Chobani’s global ambitions: Too much, too young?

By Mark Astley

At just seven years old, Chobani is a poster boy in the eyes of some, a market-devouring monster in the eyes of others. The New York-based Greek yogurt giant’s expansion plans in North America, Europe and Australasia are ambitious. But is it taking on...

The year ahead: 2013 European nutra futures

The year ahead: 2013 European nutra futures

By Shane STARLING

The economic crisis has hit the EU hard, and coupled with a severe health and nutrition claim clamp down, the past years have been challenging for the European nutra industry.

DSM broadens its range (again) with oat beta-glucan

DSM buys Swedish oat beta-glucan brand

By Shane Starling

A day after confirming the €500m acquisition of New York-based blends specialist Fortitech, Royal DSM has concluded the year by buying beta-glucan brand Oatwell from Swedish Oat Fiber (SOF).

Evolva will reduce the cost of its new yeast-derived resveratrol, it says

Evolva pays €550,000 for Fluxome resveratrol business

By Shane Starling

Swiss biotech firm Evolva has bought failing Fluxome’s, yeast-derived resveratrol business for about €550,000 in cash and shares, but says it has no interest in the remaining omega-3 business being sold by sealed auction.

Schiff MegaRed krill supplement marketing

Reckitt Benckiser-Schiff: Another giant jumps into nutra space

By Shane STARLING

UK-based consumer goods firm Reckitt Benckiser told NutraIngredients today, “nutrition had been on its radar for awhile”, as it plunged $1.4bn (€1.09bn) to outbid German pharma firm Bayer for the US’s second biggest dietary supplements firm, Schiff Nutrition...

Fortitech: Sold to DSM for €495m. Don't expect more of these kinds of buys from DSM in the near future

DSM buys Fortitech for €495m; “We are done for awhile”

By Shane Starling

Rampant nutrition business acquirer, Royal DSM, has splashed the cash for the ninth time in two years – this time to the tune of €495m ($634m) on US-based multinational nutrient blending giant, Fortitech (€212m/$270m annual turnover).

Raisio sales rise 14%; Benecol steady

Raisio sales rise 14%; Benecol steady

Ingredients, grain, snack brand and stanol-based cholesterol-lowering Benecol brand owner Raisio had a healthy Q3 with revenues up 14% to €160m from €141.7m in Q3 2011.

Nestlé 9-month sales up 11%

Emerging markets continue to drive Nestlé sales

By Oliver Nieburg

Food and nutrition giant Nestlé has reported improved sales in its 9-month results driven by growth in emerging markets, but Q3 was a little slower than last year.

Frutarom president and chief executive Ori Yehudai:

Frutarom posts powerful profit and sales growth

By Rod Addy

Frutarom has posted strong double digit growth figures for its second quarter/half year results, driven by acquisitions, organic growth, price increases, falling raw material costs and more favourable purchasing deals.

Follow us

Products

View more

Webinars